Global Injectable IVF Medications Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Injectable IVF Medications market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Injectable IVF (In Vitro Fertilization) medications are pharmaceutical drugs administered via injection to stimulate and regulate a woman's reproductive system during the fertility treatment process. These medications typically include hormones such as gonadotropins and follicle-stimulating hormone (FSH), which encourage the development of multiple eggs within the ovaries. Additionally, other drugs like human chorionic gonadotropin (hCG) are used to trigger the final maturation of eggs before retrieval. Injectable IVF medications play a crucial role in controlling the ovulation process, optimizing egg production, and enhancing the chances of successful fertilization during assisted reproductive technologies.
The fertility preservation and infertility treatment market has witnessed significant growth in recent years, driven by factors such as increasing infertility rates, delayed pregnancies, advancements in assisted reproductive technologies (ART), and growing awareness. Fertility preservation technologies, including egg freezing and sperm banking, have gained popularity among individuals seeking to preserve their reproductive potential. In the infertility treatment segment, in vitro fertilization (IVF), intrauterine insemination (IUI), and other ART procedures have become mainstream options. Future developments are anticipated in areas such as personalized medicine, gene editing technologies, and improved success rates in ART procedures. The market is likely to see ongoing advancements, innovations, and collaborations aimed at addressing infertility challenges and expanding the range of options available to individuals and couples.
The Global Info Research report includes an overview of the development of the Injectable IVF Medications industry chain, the market status of IVF and Embryo Transfer (Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH)), Infertility Treatment (Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Injectable IVF Medications.
Regionally, the report analyzes the Injectable IVF Medications markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Injectable IVF Medications market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Injectable IVF Medications market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Injectable IVF Medications industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Injectable IVF Medications market.
Regional Analysis: The report involves examining the Injectable IVF Medications market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Injectable IVF Medications market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Injectable IVF Medications:
Company Analysis: Report covers individual Injectable IVF Medications manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Injectable IVF Medications This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (IVF and Embryo Transfer, Infertility Treatment).
Technology Analysis: Report covers specific technologies relevant to Injectable IVF Medications. It assesses the current state, advancements, and potential future developments in Injectable IVF Medications areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Injectable IVF Medications market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Injectable IVF Medications market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Injectable IVF Medications product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Injectable IVF Medications, with price, sales, revenue and global market share of Injectable IVF Medications from 2019 to 2024.
Chapter 3, the Injectable IVF Medications competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Injectable IVF Medications breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Injectable IVF Medications market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Injectable IVF Medications.
Chapter 14 and 15, to describe Injectable IVF Medications sales channel, distributors, customers, research findings and conclusion.
Injectable IVF (In Vitro Fertilization) medications are pharmaceutical drugs administered via injection to stimulate and regulate a woman's reproductive system during the fertility treatment process. These medications typically include hormones such as gonadotropins and follicle-stimulating hormone (FSH), which encourage the development of multiple eggs within the ovaries. Additionally, other drugs like human chorionic gonadotropin (hCG) are used to trigger the final maturation of eggs before retrieval. Injectable IVF medications play a crucial role in controlling the ovulation process, optimizing egg production, and enhancing the chances of successful fertilization during assisted reproductive technologies.
The fertility preservation and infertility treatment market has witnessed significant growth in recent years, driven by factors such as increasing infertility rates, delayed pregnancies, advancements in assisted reproductive technologies (ART), and growing awareness. Fertility preservation technologies, including egg freezing and sperm banking, have gained popularity among individuals seeking to preserve their reproductive potential. In the infertility treatment segment, in vitro fertilization (IVF), intrauterine insemination (IUI), and other ART procedures have become mainstream options. Future developments are anticipated in areas such as personalized medicine, gene editing technologies, and improved success rates in ART procedures. The market is likely to see ongoing advancements, innovations, and collaborations aimed at addressing infertility challenges and expanding the range of options available to individuals and couples.
The Global Info Research report includes an overview of the development of the Injectable IVF Medications industry chain, the market status of IVF and Embryo Transfer (Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH)), Infertility Treatment (Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Injectable IVF Medications.
Regionally, the report analyzes the Injectable IVF Medications markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Injectable IVF Medications market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Injectable IVF Medications market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Injectable IVF Medications industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Injectable IVF Medications market.
Regional Analysis: The report involves examining the Injectable IVF Medications market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Injectable IVF Medications market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Injectable IVF Medications:
Company Analysis: Report covers individual Injectable IVF Medications manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Injectable IVF Medications This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (IVF and Embryo Transfer, Infertility Treatment).
Technology Analysis: Report covers specific technologies relevant to Injectable IVF Medications. It assesses the current state, advancements, and potential future developments in Injectable IVF Medications areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Injectable IVF Medications market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Injectable IVF Medications market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Follicle Stimulating Hormone (FSH)
- Luteinizing Hormone (LH)
- Human Chorionic Gonadotropin (hCG)
- Others
- IVF and Embryo Transfer
- Infertility Treatment
- Gonal-F (Merck)
- Follistim (Organon)
- Bravelle (Ferring)
- Menopur (Ferring)
- Fostimon (IBSA)
- Puregon (Organon)
- BEMFOLA (Gedeon Richter)
- Novarel (Ferring)
- Ovidrel (Merck)
- Synarel (Pfizer Medical)
- Follitrope (LG Chem)
- Profasi (Serum Institute Of India)
- Livzon
- GenSci
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Injectable IVF Medications product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Injectable IVF Medications, with price, sales, revenue and global market share of Injectable IVF Medications from 2019 to 2024.
Chapter 3, the Injectable IVF Medications competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Injectable IVF Medications breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Injectable IVF Medications market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Injectable IVF Medications.
Chapter 14 and 15, to describe Injectable IVF Medications sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Injectable IVF Medications
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Injectable IVF Medications Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Follicle Stimulating Hormone (FSH)
1.3.3 Luteinizing Hormone (LH)
1.3.4 Human Chorionic Gonadotropin (hCG)
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Injectable IVF Medications Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 IVF and Embryo Transfer
1.4.3 Infertility Treatment
1.5 Global Injectable IVF Medications Market Size & Forecast
1.5.1 Global Injectable IVF Medications Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Injectable IVF Medications Sales Quantity (2019-2030)
1.5.3 Global Injectable IVF Medications Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Gonal-F (Merck)
2.1.1 Gonal-F (Merck) Details
2.1.2 Gonal-F (Merck) Major Business
2.1.3 Gonal-F (Merck) Injectable IVF Medications Product and Services
2.1.4 Gonal-F (Merck) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Gonal-F (Merck) Recent Developments/Updates
2.2 Follistim (Organon)
2.2.1 Follistim (Organon) Details
2.2.2 Follistim (Organon) Major Business
2.2.3 Follistim (Organon) Injectable IVF Medications Product and Services
2.2.4 Follistim (Organon) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Follistim (Organon) Recent Developments/Updates
2.3 Bravelle (Ferring)
2.3.1 Bravelle (Ferring) Details
2.3.2 Bravelle (Ferring) Major Business
2.3.3 Bravelle (Ferring) Injectable IVF Medications Product and Services
2.3.4 Bravelle (Ferring) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bravelle (Ferring) Recent Developments/Updates
2.4 Menopur (Ferring)
2.4.1 Menopur (Ferring) Details
2.4.2 Menopur (Ferring) Major Business
2.4.3 Menopur (Ferring) Injectable IVF Medications Product and Services
2.4.4 Menopur (Ferring) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Menopur (Ferring) Recent Developments/Updates
2.5 Fostimon (IBSA)
2.5.1 Fostimon (IBSA) Details
2.5.2 Fostimon (IBSA) Major Business
2.5.3 Fostimon (IBSA) Injectable IVF Medications Product and Services
2.5.4 Fostimon (IBSA) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Fostimon (IBSA) Recent Developments/Updates
2.6 Puregon (Organon)
2.6.1 Puregon (Organon) Details
2.6.2 Puregon (Organon) Major Business
2.6.3 Puregon (Organon) Injectable IVF Medications Product and Services
2.6.4 Puregon (Organon) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Puregon (Organon) Recent Developments/Updates
2.7 BEMFOLA (Gedeon Richter)
2.7.1 BEMFOLA (Gedeon Richter) Details
2.7.2 BEMFOLA (Gedeon Richter) Major Business
2.7.3 BEMFOLA (Gedeon Richter) Injectable IVF Medications Product and Services
2.7.4 BEMFOLA (Gedeon Richter) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 BEMFOLA (Gedeon Richter) Recent Developments/Updates
2.8 Novarel (Ferring)
2.8.1 Novarel (Ferring) Details
2.8.2 Novarel (Ferring) Major Business
2.8.3 Novarel (Ferring) Injectable IVF Medications Product and Services
2.8.4 Novarel (Ferring) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Novarel (Ferring) Recent Developments/Updates
2.9 Ovidrel (Merck)
2.9.1 Ovidrel (Merck) Details
2.9.2 Ovidrel (Merck) Major Business
2.9.3 Ovidrel (Merck) Injectable IVF Medications Product and Services
2.9.4 Ovidrel (Merck) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Ovidrel (Merck) Recent Developments/Updates
2.10 Synarel (Pfizer Medical)
2.10.1 Synarel (Pfizer Medical) Details
2.10.2 Synarel (Pfizer Medical) Major Business
2.10.3 Synarel (Pfizer Medical) Injectable IVF Medications Product and Services
2.10.4 Synarel (Pfizer Medical) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Synarel (Pfizer Medical) Recent Developments/Updates
2.11 Follitrope (LG Chem)
2.11.1 Follitrope (LG Chem) Details
2.11.2 Follitrope (LG Chem) Major Business
2.11.3 Follitrope (LG Chem) Injectable IVF Medications Product and Services
2.11.4 Follitrope (LG Chem) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Follitrope (LG Chem) Recent Developments/Updates
2.12 Profasi (Serum Institute Of India)
2.12.1 Profasi (Serum Institute Of India) Details
2.12.2 Profasi (Serum Institute Of India) Major Business
2.12.3 Profasi (Serum Institute Of India) Injectable IVF Medications Product and Services
2.12.4 Profasi (Serum Institute Of India) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Profasi (Serum Institute Of India) Recent Developments/Updates
2.13 Livzon
2.13.1 Livzon Details
2.13.2 Livzon Major Business
2.13.3 Livzon Injectable IVF Medications Product and Services
2.13.4 Livzon Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Livzon Recent Developments/Updates
2.14 GenSci
2.14.1 GenSci Details
2.14.2 GenSci Major Business
2.14.3 GenSci Injectable IVF Medications Product and Services
2.14.4 GenSci Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 GenSci Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: INJECTABLE IVF MEDICATIONS BY MANUFACTURER
3.1 Global Injectable IVF Medications Sales Quantity by Manufacturer (2019-2024)
3.2 Global Injectable IVF Medications Revenue by Manufacturer (2019-2024)
3.3 Global Injectable IVF Medications Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Injectable IVF Medications by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Injectable IVF Medications Manufacturer Market Share in 2023
3.4.2 Top 6 Injectable IVF Medications Manufacturer Market Share in 2023
3.5 Injectable IVF Medications Market: Overall Company Footprint Analysis
3.5.1 Injectable IVF Medications Market: Region Footprint
3.5.2 Injectable IVF Medications Market: Company Product Type Footprint
3.5.3 Injectable IVF Medications Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Injectable IVF Medications Market Size by Region
4.1.1 Global Injectable IVF Medications Sales Quantity by Region (2019-2030)
4.1.2 Global Injectable IVF Medications Consumption Value by Region (2019-2030)
4.1.3 Global Injectable IVF Medications Average Price by Region (2019-2030)
4.2 North America Injectable IVF Medications Consumption Value (2019-2030)
4.3 Europe Injectable IVF Medications Consumption Value (2019-2030)
4.4 Asia-Pacific Injectable IVF Medications Consumption Value (2019-2030)
4.5 South America Injectable IVF Medications Consumption Value (2019-2030)
4.6 Middle East and Africa Injectable IVF Medications Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Injectable IVF Medications Sales Quantity by Type (2019-2030)
5.2 Global Injectable IVF Medications Consumption Value by Type (2019-2030)
5.3 Global Injectable IVF Medications Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Injectable IVF Medications Sales Quantity by Application (2019-2030)
6.2 Global Injectable IVF Medications Consumption Value by Application (2019-2030)
6.3 Global Injectable IVF Medications Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Injectable IVF Medications Sales Quantity by Type (2019-2030)
7.2 North America Injectable IVF Medications Sales Quantity by Application (2019-2030)
7.3 North America Injectable IVF Medications Market Size by Country
7.3.1 North America Injectable IVF Medications Sales Quantity by Country (2019-2030)
7.3.2 North America Injectable IVF Medications Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Injectable IVF Medications Sales Quantity by Type (2019-2030)
8.2 Europe Injectable IVF Medications Sales Quantity by Application (2019-2030)
8.3 Europe Injectable IVF Medications Market Size by Country
8.3.1 Europe Injectable IVF Medications Sales Quantity by Country (2019-2030)
8.3.2 Europe Injectable IVF Medications Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Injectable IVF Medications Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Injectable IVF Medications Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Injectable IVF Medications Market Size by Region
9.3.1 Asia-Pacific Injectable IVF Medications Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Injectable IVF Medications Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Injectable IVF Medications Sales Quantity by Type (2019-2030)
10.2 South America Injectable IVF Medications Sales Quantity by Application (2019-2030)
10.3 South America Injectable IVF Medications Market Size by Country
10.3.1 South America Injectable IVF Medications Sales Quantity by Country (2019-2030)
10.3.2 South America Injectable IVF Medications Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Injectable IVF Medications Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Injectable IVF Medications Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Injectable IVF Medications Market Size by Country
11.3.1 Middle East & Africa Injectable IVF Medications Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Injectable IVF Medications Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Injectable IVF Medications Market Drivers
12.2 Injectable IVF Medications Market Restraints
12.3 Injectable IVF Medications Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Injectable IVF Medications and Key Manufacturers
13.2 Manufacturing Costs Percentage of Injectable IVF Medications
13.3 Injectable IVF Medications Production Process
13.4 Injectable IVF Medications Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Injectable IVF Medications Typical Distributors
14.3 Injectable IVF Medications Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Injectable IVF Medications
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Injectable IVF Medications Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Follicle Stimulating Hormone (FSH)
1.3.3 Luteinizing Hormone (LH)
1.3.4 Human Chorionic Gonadotropin (hCG)
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Injectable IVF Medications Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 IVF and Embryo Transfer
1.4.3 Infertility Treatment
1.5 Global Injectable IVF Medications Market Size & Forecast
1.5.1 Global Injectable IVF Medications Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Injectable IVF Medications Sales Quantity (2019-2030)
1.5.3 Global Injectable IVF Medications Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Gonal-F (Merck)
2.1.1 Gonal-F (Merck) Details
2.1.2 Gonal-F (Merck) Major Business
2.1.3 Gonal-F (Merck) Injectable IVF Medications Product and Services
2.1.4 Gonal-F (Merck) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Gonal-F (Merck) Recent Developments/Updates
2.2 Follistim (Organon)
2.2.1 Follistim (Organon) Details
2.2.2 Follistim (Organon) Major Business
2.2.3 Follistim (Organon) Injectable IVF Medications Product and Services
2.2.4 Follistim (Organon) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Follistim (Organon) Recent Developments/Updates
2.3 Bravelle (Ferring)
2.3.1 Bravelle (Ferring) Details
2.3.2 Bravelle (Ferring) Major Business
2.3.3 Bravelle (Ferring) Injectable IVF Medications Product and Services
2.3.4 Bravelle (Ferring) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bravelle (Ferring) Recent Developments/Updates
2.4 Menopur (Ferring)
2.4.1 Menopur (Ferring) Details
2.4.2 Menopur (Ferring) Major Business
2.4.3 Menopur (Ferring) Injectable IVF Medications Product and Services
2.4.4 Menopur (Ferring) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Menopur (Ferring) Recent Developments/Updates
2.5 Fostimon (IBSA)
2.5.1 Fostimon (IBSA) Details
2.5.2 Fostimon (IBSA) Major Business
2.5.3 Fostimon (IBSA) Injectable IVF Medications Product and Services
2.5.4 Fostimon (IBSA) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Fostimon (IBSA) Recent Developments/Updates
2.6 Puregon (Organon)
2.6.1 Puregon (Organon) Details
2.6.2 Puregon (Organon) Major Business
2.6.3 Puregon (Organon) Injectable IVF Medications Product and Services
2.6.4 Puregon (Organon) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Puregon (Organon) Recent Developments/Updates
2.7 BEMFOLA (Gedeon Richter)
2.7.1 BEMFOLA (Gedeon Richter) Details
2.7.2 BEMFOLA (Gedeon Richter) Major Business
2.7.3 BEMFOLA (Gedeon Richter) Injectable IVF Medications Product and Services
2.7.4 BEMFOLA (Gedeon Richter) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 BEMFOLA (Gedeon Richter) Recent Developments/Updates
2.8 Novarel (Ferring)
2.8.1 Novarel (Ferring) Details
2.8.2 Novarel (Ferring) Major Business
2.8.3 Novarel (Ferring) Injectable IVF Medications Product and Services
2.8.4 Novarel (Ferring) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Novarel (Ferring) Recent Developments/Updates
2.9 Ovidrel (Merck)
2.9.1 Ovidrel (Merck) Details
2.9.2 Ovidrel (Merck) Major Business
2.9.3 Ovidrel (Merck) Injectable IVF Medications Product and Services
2.9.4 Ovidrel (Merck) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Ovidrel (Merck) Recent Developments/Updates
2.10 Synarel (Pfizer Medical)
2.10.1 Synarel (Pfizer Medical) Details
2.10.2 Synarel (Pfizer Medical) Major Business
2.10.3 Synarel (Pfizer Medical) Injectable IVF Medications Product and Services
2.10.4 Synarel (Pfizer Medical) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Synarel (Pfizer Medical) Recent Developments/Updates
2.11 Follitrope (LG Chem)
2.11.1 Follitrope (LG Chem) Details
2.11.2 Follitrope (LG Chem) Major Business
2.11.3 Follitrope (LG Chem) Injectable IVF Medications Product and Services
2.11.4 Follitrope (LG Chem) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Follitrope (LG Chem) Recent Developments/Updates
2.12 Profasi (Serum Institute Of India)
2.12.1 Profasi (Serum Institute Of India) Details
2.12.2 Profasi (Serum Institute Of India) Major Business
2.12.3 Profasi (Serum Institute Of India) Injectable IVF Medications Product and Services
2.12.4 Profasi (Serum Institute Of India) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Profasi (Serum Institute Of India) Recent Developments/Updates
2.13 Livzon
2.13.1 Livzon Details
2.13.2 Livzon Major Business
2.13.3 Livzon Injectable IVF Medications Product and Services
2.13.4 Livzon Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Livzon Recent Developments/Updates
2.14 GenSci
2.14.1 GenSci Details
2.14.2 GenSci Major Business
2.14.3 GenSci Injectable IVF Medications Product and Services
2.14.4 GenSci Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 GenSci Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: INJECTABLE IVF MEDICATIONS BY MANUFACTURER
3.1 Global Injectable IVF Medications Sales Quantity by Manufacturer (2019-2024)
3.2 Global Injectable IVF Medications Revenue by Manufacturer (2019-2024)
3.3 Global Injectable IVF Medications Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Injectable IVF Medications by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Injectable IVF Medications Manufacturer Market Share in 2023
3.4.2 Top 6 Injectable IVF Medications Manufacturer Market Share in 2023
3.5 Injectable IVF Medications Market: Overall Company Footprint Analysis
3.5.1 Injectable IVF Medications Market: Region Footprint
3.5.2 Injectable IVF Medications Market: Company Product Type Footprint
3.5.3 Injectable IVF Medications Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Injectable IVF Medications Market Size by Region
4.1.1 Global Injectable IVF Medications Sales Quantity by Region (2019-2030)
4.1.2 Global Injectable IVF Medications Consumption Value by Region (2019-2030)
4.1.3 Global Injectable IVF Medications Average Price by Region (2019-2030)
4.2 North America Injectable IVF Medications Consumption Value (2019-2030)
4.3 Europe Injectable IVF Medications Consumption Value (2019-2030)
4.4 Asia-Pacific Injectable IVF Medications Consumption Value (2019-2030)
4.5 South America Injectable IVF Medications Consumption Value (2019-2030)
4.6 Middle East and Africa Injectable IVF Medications Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Injectable IVF Medications Sales Quantity by Type (2019-2030)
5.2 Global Injectable IVF Medications Consumption Value by Type (2019-2030)
5.3 Global Injectable IVF Medications Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Injectable IVF Medications Sales Quantity by Application (2019-2030)
6.2 Global Injectable IVF Medications Consumption Value by Application (2019-2030)
6.3 Global Injectable IVF Medications Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Injectable IVF Medications Sales Quantity by Type (2019-2030)
7.2 North America Injectable IVF Medications Sales Quantity by Application (2019-2030)
7.3 North America Injectable IVF Medications Market Size by Country
7.3.1 North America Injectable IVF Medications Sales Quantity by Country (2019-2030)
7.3.2 North America Injectable IVF Medications Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Injectable IVF Medications Sales Quantity by Type (2019-2030)
8.2 Europe Injectable IVF Medications Sales Quantity by Application (2019-2030)
8.3 Europe Injectable IVF Medications Market Size by Country
8.3.1 Europe Injectable IVF Medications Sales Quantity by Country (2019-2030)
8.3.2 Europe Injectable IVF Medications Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Injectable IVF Medications Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Injectable IVF Medications Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Injectable IVF Medications Market Size by Region
9.3.1 Asia-Pacific Injectable IVF Medications Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Injectable IVF Medications Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Injectable IVF Medications Sales Quantity by Type (2019-2030)
10.2 South America Injectable IVF Medications Sales Quantity by Application (2019-2030)
10.3 South America Injectable IVF Medications Market Size by Country
10.3.1 South America Injectable IVF Medications Sales Quantity by Country (2019-2030)
10.3.2 South America Injectable IVF Medications Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Injectable IVF Medications Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Injectable IVF Medications Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Injectable IVF Medications Market Size by Country
11.3.1 Middle East & Africa Injectable IVF Medications Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Injectable IVF Medications Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Injectable IVF Medications Market Drivers
12.2 Injectable IVF Medications Market Restraints
12.3 Injectable IVF Medications Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Injectable IVF Medications and Key Manufacturers
13.2 Manufacturing Costs Percentage of Injectable IVF Medications
13.3 Injectable IVF Medications Production Process
13.4 Injectable IVF Medications Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Injectable IVF Medications Typical Distributors
14.3 Injectable IVF Medications Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Injectable IVF Medications Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Injectable IVF Medications Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Gonal-F (Merck) Basic Information, Manufacturing Base and Competitors
Table 4. Gonal-F (Merck) Major Business
Table 5. Gonal-F (Merck) Injectable IVF Medications Product and Services
Table 6. Gonal-F (Merck) Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Gonal-F (Merck) Recent Developments/Updates
Table 8. Follistim (Organon) Basic Information, Manufacturing Base and Competitors
Table 9. Follistim (Organon) Major Business
Table 10. Follistim (Organon) Injectable IVF Medications Product and Services
Table 11. Follistim (Organon) Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Follistim (Organon) Recent Developments/Updates
Table 13. Bravelle (Ferring) Basic Information, Manufacturing Base and Competitors
Table 14. Bravelle (Ferring) Major Business
Table 15. Bravelle (Ferring) Injectable IVF Medications Product and Services
Table 16. Bravelle (Ferring) Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Bravelle (Ferring) Recent Developments/Updates
Table 18. Menopur (Ferring) Basic Information, Manufacturing Base and Competitors
Table 19. Menopur (Ferring) Major Business
Table 20. Menopur (Ferring) Injectable IVF Medications Product and Services
Table 21. Menopur (Ferring) Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Menopur (Ferring) Recent Developments/Updates
Table 23. Fostimon (IBSA) Basic Information, Manufacturing Base and Competitors
Table 24. Fostimon (IBSA) Major Business
Table 25. Fostimon (IBSA) Injectable IVF Medications Product and Services
Table 26. Fostimon (IBSA) Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Fostimon (IBSA) Recent Developments/Updates
Table 28. Puregon (Organon) Basic Information, Manufacturing Base and Competitors
Table 29. Puregon (Organon) Major Business
Table 30. Puregon (Organon) Injectable IVF Medications Product and Services
Table 31. Puregon (Organon) Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Puregon (Organon) Recent Developments/Updates
Table 33. BEMFOLA (Gedeon Richter) Basic Information, Manufacturing Base and Competitors
Table 34. BEMFOLA (Gedeon Richter) Major Business
Table 35. BEMFOLA (Gedeon Richter) Injectable IVF Medications Product and Services
Table 36. BEMFOLA (Gedeon Richter) Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. BEMFOLA (Gedeon Richter) Recent Developments/Updates
Table 38. Novarel (Ferring) Basic Information, Manufacturing Base and Competitors
Table 39. Novarel (Ferring) Major Business
Table 40. Novarel (Ferring) Injectable IVF Medications Product and Services
Table 41. Novarel (Ferring) Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Novarel (Ferring) Recent Developments/Updates
Table 43. Ovidrel (Merck) Basic Information, Manufacturing Base and Competitors
Table 44. Ovidrel (Merck) Major Business
Table 45. Ovidrel (Merck) Injectable IVF Medications Product and Services
Table 46. Ovidrel (Merck) Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Ovidrel (Merck) Recent Developments/Updates
Table 48. Synarel (Pfizer Medical) Basic Information, Manufacturing Base and Competitors
Table 49. Synarel (Pfizer Medical) Major Business
Table 50. Synarel (Pfizer Medical) Injectable IVF Medications Product and Services
Table 51. Synarel (Pfizer Medical) Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Synarel (Pfizer Medical) Recent Developments/Updates
Table 53. Follitrope (LG Chem) Basic Information, Manufacturing Base and Competitors
Table 54. Follitrope (LG Chem) Major Business
Table 55. Follitrope (LG Chem) Injectable IVF Medications Product and Services
Table 56. Follitrope (LG Chem) Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Follitrope (LG Chem) Recent Developments/Updates
Table 58. Profasi (Serum Institute Of India) Basic Information, Manufacturing Base and Competitors
Table 59. Profasi (Serum Institute Of India) Major Business
Table 60. Profasi (Serum Institute Of India) Injectable IVF Medications Product and Services
Table 61. Profasi (Serum Institute Of India) Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Profasi (Serum Institute Of India) Recent Developments/Updates
Table 63. Livzon Basic Information, Manufacturing Base and Competitors
Table 64. Livzon Major Business
Table 65. Livzon Injectable IVF Medications Product and Services
Table 66. Livzon Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Livzon Recent Developments/Updates
Table 68. GenSci Basic Information, Manufacturing Base and Competitors
Table 69. GenSci Major Business
Table 70. GenSci Injectable IVF Medications Product and Services
Table 71. GenSci Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. GenSci Recent Developments/Updates
Table 73. Global Injectable IVF Medications Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 74. Global Injectable IVF Medications Revenue by Manufacturer (2019-2024) & (USD Million)
Table 75. Global Injectable IVF Medications Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 76. Market Position of Manufacturers in Injectable IVF Medications, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 77. Head Office and Injectable IVF Medications Production Site of Key Manufacturer
Table 78. Injectable IVF Medications Market: Company Product Type Footprint
Table 79. Injectable IVF Medications Market: Company Product Application Footprint
Table 80. Injectable IVF Medications New Market Entrants and Barriers to Market Entry
Table 81. Injectable IVF Medications Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Injectable IVF Medications Sales Quantity by Region (2019-2024) & (K Units)
Table 83. Global Injectable IVF Medications Sales Quantity by Region (2025-2030) & (K Units)
Table 84. Global Injectable IVF Medications Consumption Value by Region (2019-2024) & (USD Million)
Table 85. Global Injectable IVF Medications Consumption Value by Region (2025-2030) & (USD Million)
Table 86. Global Injectable IVF Medications Average Price by Region (2019-2024) & (US$/Unit)
Table 87. Global Injectable IVF Medications Average Price by Region (2025-2030) & (US$/Unit)
Table 88. Global Injectable IVF Medications Sales Quantity by Type (2019-2024) & (K Units)
Table 89. Global Injectable IVF Medications Sales Quantity by Type (2025-2030) & (K Units)
Table 90. Global Injectable IVF Medications Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Global Injectable IVF Medications Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Global Injectable IVF Medications Average Price by Type (2019-2024) & (US$/Unit)
Table 93. Global Injectable IVF Medications Average Price by Type (2025-2030) & (US$/Unit)
Table 94. Global Injectable IVF Medications Sales Quantity by Application (2019-2024) & (K Units)
Table 95. Global Injectable IVF Medications Sales Quantity by Application (2025-2030) & (K Units)
Table 96. Global Injectable IVF Medications Consumption Value by Application (2019-2024) & (USD Million)
Table 97. Global Injectable IVF Medications Consumption Value by Application (2025-2030) & (USD Million)
Table 98. Global Injectable IVF Medications Average Price by Application (2019-2024) & (US$/Unit)
Table 99. Global Injectable IVF Medications Average Price by Application (2025-2030) & (US$/Unit)
Table 100. North America Injectable IVF Medications Sales Quantity by Type (2019-2024) & (K Units)
Table 101. North America Injectable IVF Medications Sales Quantity by Type (2025-2030) & (K Units)
Table 102. North America Injectable IVF Medications Sales Quantity by Application (2019-2024) & (K Units)
Table 103. North America Injectable IVF Medications Sales Quantity by Application (2025-2030) & (K Units)
Table 104. North America Injectable IVF Medications Sales Quantity by Country (2019-2024) & (K Units)
Table 105. North America Injectable IVF Medications Sales Quantity by Country (2025-2030) & (K Units)
Table 106. North America Injectable IVF Medications Consumption Value by Country (2019-2024) & (USD Million)
Table 107. North America Injectable IVF Medications Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Europe Injectable IVF Medications Sales Quantity by Type (2019-2024) & (K Units)
Table 109. Europe Injectable IVF Medications Sales Quantity by Type (2025-2030) & (K Units)
Table 110. Europe Injectable IVF Medications Sales Quantity by Application (2019-2024) & (K Units)
Table 111. Europe Injectable IVF Medications Sales Quantity by Application (2025-2030) & (K Units)
Table 112. Europe Injectable IVF Medications Sales Quantity by Country (2019-2024) & (K Units)
Table 113. Europe Injectable IVF Medications Sales Quantity by Country (2025-2030) & (K Units)
Table 114. Europe Injectable IVF Medications Consumption Value by Country (2019-2024) & (USD Million)
Table 115. Europe Injectable IVF Medications Consumption Value by Country (2025-2030) & (USD Million)
Table 116. Asia-Pacific Injectable IVF Medications Sales Quantity by Type (2019-2024) & (K Units)
Table 117. Asia-Pacific Injectable IVF Medications Sales Quantity by Type (2025-2030) & (K Units)
Table 118. Asia-Pacific Injectable IVF Medications Sales Quantity by Application (2019-2024) & (K Units)
Table 119. Asia-Pacific Injectable IVF Medications Sales Quantity by Application (2025-2030) & (K Units)
Table 120. Asia-Pacific Injectable IVF Medications Sales Quantity by Region (2019-2024) & (K Units)
Table 121. Asia-Pacific Injectable IVF Medications Sales Quantity by Region (2025-2030) & (K Units)
Table 122. Asia-Pacific Injectable IVF Medications Consumption Value by Region (2019-2024) & (USD Million)
Table 123. Asia-Pacific Injectable IVF Medications Consumption Value by Region (2025-2030) & (USD Million)
Table 124. South America Injectable IVF Medications Sales Quantity by Type (2019-2024) & (K Units)
Table 125. South America Injectable IVF Medications Sales Quantity by Type (2025-2030) & (K Units)
Table 126. South America Injectable IVF Medications Sales Quantity by Application (2019-2024) & (K Units)
Table 127. South America Injectable IVF Medications Sales Quantity by Application (2025-2030) & (K Units)
Table 128. South America Injectable IVF Medications Sales Quantity by Country (2019-2024) & (K Units)
Table 129. South America Injectable IVF Medications Sales Quantity by Country (2025-2030) & (K Units)
Table 130. South America Injectable IVF Medications Consumption Value by Country (2019-2024) & (USD Million)
Table 131. South America Injectable IVF Medications Consumption Value by Country (2025-2030) & (USD Million)
Table 132. Middle East & Africa Injectable IVF Medications Sales Quantity by Type (2019-2024) & (K Units)
Table 133. Middle East & Africa Injectable IVF Medications Sales Quantity by Type (2025-2030) & (K Units)
Table 134. Middle East & Africa Injectable IVF Medications Sales Quantity by Application (2019-2024) & (K Units)
Table 135. Middle East & Africa Injectable IVF Medications Sales Quantity by Application (2025-2030) & (K Units)
Table 136. Middle East & Africa Injectable IVF Medications Sales Quantity by Region (2019-2024) & (K Units)
Table 137. Middle East & Africa Injectable IVF Medications Sales Quantity by Region (2025-2030) & (K Units)
Table 138. Middle East & Africa Injectable IVF Medications Consumption Value by Region (2019-2024) & (USD Million)
Table 139. Middle East & Africa Injectable IVF Medications Consumption Value by Region (2025-2030) & (USD Million)
Table 140. Injectable IVF Medications Raw Material
Table 141. Key Manufacturers of Injectable IVF Medications Raw Materials
Table 142. Injectable IVF Medications Typical Distributors
Table 143. Injectable IVF Medications Typical Customers
LIST OF FIGURE
s
Figure 1. Injectable IVF Medications Picture
Figure 2. Global Injectable IVF Medications Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Injectable IVF Medications Consumption Value Market Share by Type in 2023
Figure 4. Follicle Stimulating Hormone (FSH) Examples
Figure 5. Luteinizing Hormone (LH) Examples
Figure 6. Human Chorionic Gonadotropin (hCG) Examples
Figure 7. Others Examples
Figure 8. Global Injectable IVF Medications Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Injectable IVF Medications Consumption Value Market Share by Application in 2023
Figure 10. IVF and Embryo Transfer Examples
Figure 11. Infertility Treatment Examples
Figure 12. Global Injectable IVF Medications Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Injectable IVF Medications Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Injectable IVF Medications Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Injectable IVF Medications Average Price (2019-2030) & (US$/Unit)
Figure 16. Global Injectable IVF Medications Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Injectable IVF Medications Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Injectable IVF Medications by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Injectable IVF Medications Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Injectable IVF Medications Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Injectable IVF Medications Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Injectable IVF Medications Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Injectable IVF Medications Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Injectable IVF Medications Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Injectable IVF Medications Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Injectable IVF Medications Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Injectable IVF Medications Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Injectable IVF Medications Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Injectable IVF Medications Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Injectable IVF Medications Average Price by Type (2019-2030) & (US$/Unit)
Figure 31. Global Injectable IVF Medications Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Injectable IVF Medications Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Injectable IVF Medications Average Price by Application (2019-2030) & (US$/Unit)
Figure 34. North America Injectable IVF Medications Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Injectable IVF Medications Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Injectable IVF Medications Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Injectable IVF Medications Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Injectable IVF Medications Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Injectable IVF Medications Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Injectable IVF Medications Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Injectable IVF Medications Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Injectable IVF Medications Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Injectable IVF Medications Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Injectable IVF Medications Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Injectable IVF Medications Consumption Value Market Share by Region (2019-2030)
Figure 54. China Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Injectable IVF Medications Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Injectable IVF Medications Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Injectable IVF Medications Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Injectable IVF Medications Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Injectable IVF Medications Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Injectable IVF Medications Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Injectable IVF Medications Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Injectable IVF Medications Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Injectable IVF Medications Market Drivers
Figure 75. Injectable IVF Medications Market Restraints
Figure 76. Injectable IVF Medications Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Injectable IVF Medications in 2023
Figure 79. Manufacturing Process Analysis of Injectable IVF Medications
Figure 80. Injectable IVF Medications Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Table 1. Global Injectable IVF Medications Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Injectable IVF Medications Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Gonal-F (Merck) Basic Information, Manufacturing Base and Competitors
Table 4. Gonal-F (Merck) Major Business
Table 5. Gonal-F (Merck) Injectable IVF Medications Product and Services
Table 6. Gonal-F (Merck) Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Gonal-F (Merck) Recent Developments/Updates
Table 8. Follistim (Organon) Basic Information, Manufacturing Base and Competitors
Table 9. Follistim (Organon) Major Business
Table 10. Follistim (Organon) Injectable IVF Medications Product and Services
Table 11. Follistim (Organon) Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Follistim (Organon) Recent Developments/Updates
Table 13. Bravelle (Ferring) Basic Information, Manufacturing Base and Competitors
Table 14. Bravelle (Ferring) Major Business
Table 15. Bravelle (Ferring) Injectable IVF Medications Product and Services
Table 16. Bravelle (Ferring) Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Bravelle (Ferring) Recent Developments/Updates
Table 18. Menopur (Ferring) Basic Information, Manufacturing Base and Competitors
Table 19. Menopur (Ferring) Major Business
Table 20. Menopur (Ferring) Injectable IVF Medications Product and Services
Table 21. Menopur (Ferring) Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Menopur (Ferring) Recent Developments/Updates
Table 23. Fostimon (IBSA) Basic Information, Manufacturing Base and Competitors
Table 24. Fostimon (IBSA) Major Business
Table 25. Fostimon (IBSA) Injectable IVF Medications Product and Services
Table 26. Fostimon (IBSA) Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Fostimon (IBSA) Recent Developments/Updates
Table 28. Puregon (Organon) Basic Information, Manufacturing Base and Competitors
Table 29. Puregon (Organon) Major Business
Table 30. Puregon (Organon) Injectable IVF Medications Product and Services
Table 31. Puregon (Organon) Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Puregon (Organon) Recent Developments/Updates
Table 33. BEMFOLA (Gedeon Richter) Basic Information, Manufacturing Base and Competitors
Table 34. BEMFOLA (Gedeon Richter) Major Business
Table 35. BEMFOLA (Gedeon Richter) Injectable IVF Medications Product and Services
Table 36. BEMFOLA (Gedeon Richter) Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. BEMFOLA (Gedeon Richter) Recent Developments/Updates
Table 38. Novarel (Ferring) Basic Information, Manufacturing Base and Competitors
Table 39. Novarel (Ferring) Major Business
Table 40. Novarel (Ferring) Injectable IVF Medications Product and Services
Table 41. Novarel (Ferring) Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Novarel (Ferring) Recent Developments/Updates
Table 43. Ovidrel (Merck) Basic Information, Manufacturing Base and Competitors
Table 44. Ovidrel (Merck) Major Business
Table 45. Ovidrel (Merck) Injectable IVF Medications Product and Services
Table 46. Ovidrel (Merck) Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Ovidrel (Merck) Recent Developments/Updates
Table 48. Synarel (Pfizer Medical) Basic Information, Manufacturing Base and Competitors
Table 49. Synarel (Pfizer Medical) Major Business
Table 50. Synarel (Pfizer Medical) Injectable IVF Medications Product and Services
Table 51. Synarel (Pfizer Medical) Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Synarel (Pfizer Medical) Recent Developments/Updates
Table 53. Follitrope (LG Chem) Basic Information, Manufacturing Base and Competitors
Table 54. Follitrope (LG Chem) Major Business
Table 55. Follitrope (LG Chem) Injectable IVF Medications Product and Services
Table 56. Follitrope (LG Chem) Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Follitrope (LG Chem) Recent Developments/Updates
Table 58. Profasi (Serum Institute Of India) Basic Information, Manufacturing Base and Competitors
Table 59. Profasi (Serum Institute Of India) Major Business
Table 60. Profasi (Serum Institute Of India) Injectable IVF Medications Product and Services
Table 61. Profasi (Serum Institute Of India) Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Profasi (Serum Institute Of India) Recent Developments/Updates
Table 63. Livzon Basic Information, Manufacturing Base and Competitors
Table 64. Livzon Major Business
Table 65. Livzon Injectable IVF Medications Product and Services
Table 66. Livzon Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Livzon Recent Developments/Updates
Table 68. GenSci Basic Information, Manufacturing Base and Competitors
Table 69. GenSci Major Business
Table 70. GenSci Injectable IVF Medications Product and Services
Table 71. GenSci Injectable IVF Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. GenSci Recent Developments/Updates
Table 73. Global Injectable IVF Medications Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 74. Global Injectable IVF Medications Revenue by Manufacturer (2019-2024) & (USD Million)
Table 75. Global Injectable IVF Medications Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 76. Market Position of Manufacturers in Injectable IVF Medications, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 77. Head Office and Injectable IVF Medications Production Site of Key Manufacturer
Table 78. Injectable IVF Medications Market: Company Product Type Footprint
Table 79. Injectable IVF Medications Market: Company Product Application Footprint
Table 80. Injectable IVF Medications New Market Entrants and Barriers to Market Entry
Table 81. Injectable IVF Medications Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Injectable IVF Medications Sales Quantity by Region (2019-2024) & (K Units)
Table 83. Global Injectable IVF Medications Sales Quantity by Region (2025-2030) & (K Units)
Table 84. Global Injectable IVF Medications Consumption Value by Region (2019-2024) & (USD Million)
Table 85. Global Injectable IVF Medications Consumption Value by Region (2025-2030) & (USD Million)
Table 86. Global Injectable IVF Medications Average Price by Region (2019-2024) & (US$/Unit)
Table 87. Global Injectable IVF Medications Average Price by Region (2025-2030) & (US$/Unit)
Table 88. Global Injectable IVF Medications Sales Quantity by Type (2019-2024) & (K Units)
Table 89. Global Injectable IVF Medications Sales Quantity by Type (2025-2030) & (K Units)
Table 90. Global Injectable IVF Medications Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Global Injectable IVF Medications Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Global Injectable IVF Medications Average Price by Type (2019-2024) & (US$/Unit)
Table 93. Global Injectable IVF Medications Average Price by Type (2025-2030) & (US$/Unit)
Table 94. Global Injectable IVF Medications Sales Quantity by Application (2019-2024) & (K Units)
Table 95. Global Injectable IVF Medications Sales Quantity by Application (2025-2030) & (K Units)
Table 96. Global Injectable IVF Medications Consumption Value by Application (2019-2024) & (USD Million)
Table 97. Global Injectable IVF Medications Consumption Value by Application (2025-2030) & (USD Million)
Table 98. Global Injectable IVF Medications Average Price by Application (2019-2024) & (US$/Unit)
Table 99. Global Injectable IVF Medications Average Price by Application (2025-2030) & (US$/Unit)
Table 100. North America Injectable IVF Medications Sales Quantity by Type (2019-2024) & (K Units)
Table 101. North America Injectable IVF Medications Sales Quantity by Type (2025-2030) & (K Units)
Table 102. North America Injectable IVF Medications Sales Quantity by Application (2019-2024) & (K Units)
Table 103. North America Injectable IVF Medications Sales Quantity by Application (2025-2030) & (K Units)
Table 104. North America Injectable IVF Medications Sales Quantity by Country (2019-2024) & (K Units)
Table 105. North America Injectable IVF Medications Sales Quantity by Country (2025-2030) & (K Units)
Table 106. North America Injectable IVF Medications Consumption Value by Country (2019-2024) & (USD Million)
Table 107. North America Injectable IVF Medications Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Europe Injectable IVF Medications Sales Quantity by Type (2019-2024) & (K Units)
Table 109. Europe Injectable IVF Medications Sales Quantity by Type (2025-2030) & (K Units)
Table 110. Europe Injectable IVF Medications Sales Quantity by Application (2019-2024) & (K Units)
Table 111. Europe Injectable IVF Medications Sales Quantity by Application (2025-2030) & (K Units)
Table 112. Europe Injectable IVF Medications Sales Quantity by Country (2019-2024) & (K Units)
Table 113. Europe Injectable IVF Medications Sales Quantity by Country (2025-2030) & (K Units)
Table 114. Europe Injectable IVF Medications Consumption Value by Country (2019-2024) & (USD Million)
Table 115. Europe Injectable IVF Medications Consumption Value by Country (2025-2030) & (USD Million)
Table 116. Asia-Pacific Injectable IVF Medications Sales Quantity by Type (2019-2024) & (K Units)
Table 117. Asia-Pacific Injectable IVF Medications Sales Quantity by Type (2025-2030) & (K Units)
Table 118. Asia-Pacific Injectable IVF Medications Sales Quantity by Application (2019-2024) & (K Units)
Table 119. Asia-Pacific Injectable IVF Medications Sales Quantity by Application (2025-2030) & (K Units)
Table 120. Asia-Pacific Injectable IVF Medications Sales Quantity by Region (2019-2024) & (K Units)
Table 121. Asia-Pacific Injectable IVF Medications Sales Quantity by Region (2025-2030) & (K Units)
Table 122. Asia-Pacific Injectable IVF Medications Consumption Value by Region (2019-2024) & (USD Million)
Table 123. Asia-Pacific Injectable IVF Medications Consumption Value by Region (2025-2030) & (USD Million)
Table 124. South America Injectable IVF Medications Sales Quantity by Type (2019-2024) & (K Units)
Table 125. South America Injectable IVF Medications Sales Quantity by Type (2025-2030) & (K Units)
Table 126. South America Injectable IVF Medications Sales Quantity by Application (2019-2024) & (K Units)
Table 127. South America Injectable IVF Medications Sales Quantity by Application (2025-2030) & (K Units)
Table 128. South America Injectable IVF Medications Sales Quantity by Country (2019-2024) & (K Units)
Table 129. South America Injectable IVF Medications Sales Quantity by Country (2025-2030) & (K Units)
Table 130. South America Injectable IVF Medications Consumption Value by Country (2019-2024) & (USD Million)
Table 131. South America Injectable IVF Medications Consumption Value by Country (2025-2030) & (USD Million)
Table 132. Middle East & Africa Injectable IVF Medications Sales Quantity by Type (2019-2024) & (K Units)
Table 133. Middle East & Africa Injectable IVF Medications Sales Quantity by Type (2025-2030) & (K Units)
Table 134. Middle East & Africa Injectable IVF Medications Sales Quantity by Application (2019-2024) & (K Units)
Table 135. Middle East & Africa Injectable IVF Medications Sales Quantity by Application (2025-2030) & (K Units)
Table 136. Middle East & Africa Injectable IVF Medications Sales Quantity by Region (2019-2024) & (K Units)
Table 137. Middle East & Africa Injectable IVF Medications Sales Quantity by Region (2025-2030) & (K Units)
Table 138. Middle East & Africa Injectable IVF Medications Consumption Value by Region (2019-2024) & (USD Million)
Table 139. Middle East & Africa Injectable IVF Medications Consumption Value by Region (2025-2030) & (USD Million)
Table 140. Injectable IVF Medications Raw Material
Table 141. Key Manufacturers of Injectable IVF Medications Raw Materials
Table 142. Injectable IVF Medications Typical Distributors
Table 143. Injectable IVF Medications Typical Customers
LIST OF FIGURE
s
Figure 1. Injectable IVF Medications Picture
Figure 2. Global Injectable IVF Medications Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Injectable IVF Medications Consumption Value Market Share by Type in 2023
Figure 4. Follicle Stimulating Hormone (FSH) Examples
Figure 5. Luteinizing Hormone (LH) Examples
Figure 6. Human Chorionic Gonadotropin (hCG) Examples
Figure 7. Others Examples
Figure 8. Global Injectable IVF Medications Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Injectable IVF Medications Consumption Value Market Share by Application in 2023
Figure 10. IVF and Embryo Transfer Examples
Figure 11. Infertility Treatment Examples
Figure 12. Global Injectable IVF Medications Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Injectable IVF Medications Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Injectable IVF Medications Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Injectable IVF Medications Average Price (2019-2030) & (US$/Unit)
Figure 16. Global Injectable IVF Medications Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Injectable IVF Medications Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Injectable IVF Medications by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Injectable IVF Medications Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Injectable IVF Medications Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Injectable IVF Medications Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Injectable IVF Medications Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Injectable IVF Medications Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Injectable IVF Medications Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Injectable IVF Medications Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Injectable IVF Medications Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Injectable IVF Medications Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Injectable IVF Medications Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Injectable IVF Medications Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Injectable IVF Medications Average Price by Type (2019-2030) & (US$/Unit)
Figure 31. Global Injectable IVF Medications Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Injectable IVF Medications Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Injectable IVF Medications Average Price by Application (2019-2030) & (US$/Unit)
Figure 34. North America Injectable IVF Medications Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Injectable IVF Medications Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Injectable IVF Medications Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Injectable IVF Medications Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Injectable IVF Medications Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Injectable IVF Medications Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Injectable IVF Medications Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Injectable IVF Medications Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Injectable IVF Medications Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Injectable IVF Medications Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Injectable IVF Medications Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Injectable IVF Medications Consumption Value Market Share by Region (2019-2030)
Figure 54. China Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Injectable IVF Medications Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Injectable IVF Medications Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Injectable IVF Medications Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Injectable IVF Medications Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Injectable IVF Medications Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Injectable IVF Medications Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Injectable IVF Medications Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Injectable IVF Medications Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Injectable IVF Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Injectable IVF Medications Market Drivers
Figure 75. Injectable IVF Medications Market Restraints
Figure 76. Injectable IVF Medications Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Injectable IVF Medications in 2023
Figure 79. Manufacturing Process Analysis of Injectable IVF Medications
Figure 80. Injectable IVF Medications Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
